Sands Capital Management
BSX icon

Sands Capital Management’s Boston Scientific BSX Stock Holding History

Sands Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-736,109
Closed -$46.2M – 73
2026
Q1 		$46.2M Sell
736,109
-69,055
-9% -$5.52M 0.18% 47
2025
Q4 		$76.8M Buy
+805,164
New +$78.9M 0.23% 50
2021
Q1 		– Sell
-1,622,282
Closed -$58.3M – 77
2020
Q4 		$58.3M Buy
1,622,282
+59,571
+4% +$2.15M 0.11% 69
2020
Q3 		$59.7M Sell
1,562,711
-23,713
-1% -$914K 0.13% 63
2020
Q2 		$55.7M Buy
1,586,424
+387,743
+32% +$14M 0.13% 61
2020
Q1 		$39.1M Buy
1,198,681
+4,525
+0.4% +$177K 0.13% 63
2019
Q4 		$54M Buy
1,194,156
+394,072
+49% +$16.5M 0.16% 54
2019
Q3 		$32.6M Buy
800,084
+229,560
+40% +$9.73M 0.1% 60
2019
Q2 		$24.5M Buy
570,524
+410,331
+256% +$15.8M 0.07% 64
2019
Q1 		$6.15M Buy
+160,193
New +$6.12M 0.02% 67

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sands Capital Management's BSX Position: Q2 2026 in Review

Sands Capital Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 736,109 shares — an estimated $46.2M sold.

Sands Capital Management first reported a position in BSX in Q1 2019 and held it in 10 quarters. The position peaked at $76.8M in Q4 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Sands Capital Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Sands Capital Management sold 736,109 Boston Scientific shares in Q2 2026, an estimated $46.2M.
  • Sands Capital Management first reported a position in Boston Scientific in Q1 2019 and held it in 10 quarters.
  • Sands Capital Management's Boston Scientific position peaked at $76.8M in Q4 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Sands Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.